Global /Canada /Healthcare /Biotechnology /ENBI

Entheon Biomedical Corp.

ENBI

• CSE: ENBI • Delayed

0.1000CAD 0%

0.0719 USD

As of 6 June 2026, Entheon Biomedical Corp. has a market cap of $993.51K USD, ranking #48515 globally and #2700 in Canada. It ranks #4310 in the Healthcare sector, and #840 in the Biotechnology industry.

Global Rank

48515

Country Rank

2700

Sector Rank

4310

Industry Rank

840

Key Stats

Market Cap

$993.51KUSD

1.39M CAD

Enterprise Value

$722.12KUSD

1.0M CAD

Net Income (TTM)

-$199.38KUSD

-278.13K CAD

PB Ratio

6.2

Company Profile

Country (HQ)

Canada

Sector

Healthcare

Industry

Biotechnology

CEO

Timothy Ko open_in_new

Employees

Website

entheonbiomedical.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	11%	18%	18%	-9.1%	-46%	-41%	-67%	-99%

Upcoming Earnings

Earnings Date

Tue, Jun 30

News

Markets

Exchange	Ticker	Price	Quotes
Canadian Securities Exchange (CSE) MIC: XCNQ PRIMARY	ENBI Entheon Biomedical Corp Ordinary Shares ISIN: CA29383X2023 Shares Out.: Shares Outstanding: 13.859M¹ Shares Float: 12.809M² TV: TradingView: CSE: ENBI SA: Stock Analysis: CSE: ENBI YF: Yahoo Finance: ENBI.CN GF: Google Finance: CNSX: ENBI BA: Barron's: ENBI MS: Morningstar: XCNQ: ENBI	0.1000 CAD	TV: TradingView: CSE: ENBI SA: Stock Analysis: CSE: ENBI YF: Yahoo Finance: ENBI.CN GF: Google Finance: CNSX: ENBI BA: Barron's: ENBI MS: Morningstar: XCNQ: ENBI
Cboe Canada (NEO) MIC: NEOE	ENBI Entheon Biomedical Corp Ordinary Shares ISIN: CA29383X2023 TV: TradingView: NEO: ENBI SA: Stock Analysis: NEO: ENBI YF: Yahoo Finance: ENBI.NE GF: Google Finance: NEO: ENBI BA: Barron's: ENBI MS: Morningstar: NEOE: ENBI	0.1200 CAD	TV: TradingView: NEO: ENBI SA: Stock Analysis: NEO: ENBI YF: Yahoo Finance: ENBI.NE GF: Google Finance: NEO: ENBI BA: Barron's: ENBI MS: Morningstar: NEOE: ENBI
OTC Markets (OTCMKTS / OTC) MIC: OTCM	ENTBF Entheon Biomedical Corp Ordinary Shares ISIN: CA29383X2023 TV: TradingView: OTC: ENTBF SA: Stock Analysis: OTC: ENTBF YF: Yahoo Finance: ENTBF GF: Google Finance: OTCMKTS: ENTBF BA: Barron's: ENTBF MS: Morningstar: PINX: ENTBF	0.0770 USD	TV: TradingView: OTC: ENTBF SA: Stock Analysis: OTC: ENTBF YF: Yahoo Finance: ENTBF GF: Google Finance: OTCMKTS: ENTBF BA: Barron's: ENTBF MS: Morningstar: PINX: ENTBF

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Entheon Biomedical Corp.

Entheon Biomedical Corp. operates as a biotechnology research and development company. It develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.

Similar Companies

Industry: Biotechnology (Canada)

Name	Market Cap (USD) diff.	PE	Country
Aurinia Pharmaceuticals Inc. NASDAQ: AUPH	$1.99B 200K%	7.4	Canada
AbCellera Biologics Inc. NASDAQ: ABCL	$1.16B 116K%	-	Canada
Eupraxia Pharmaceuticals Inc. TSX: EPRX	$430.76M 600.89M CAD 43K%	-	Canada
NervGen Pharma Corp. TSXV: NGEN	$294.06M 410.19M CAD 29K%	-	Canada
Cybin Inc. NEO: CYBN	$253.15M 353.13M CAD 25K%	-	Canada
Cardiol Therapeutics Inc. TSX: CRDL	$149.17M 208.08M CAD 15K%	-	Canada

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 18M%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 16M%	19.0	United States
argenx SE EBR: ARGX	$48.08B 41.39B EUR 5M%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.48B 68.19T KRW 4M%	35.5	South Korea
CSL Ltd. ASX: CSL	$43.01B 60.27B AUD 4M%	29.3	Australia
Lonza Group AG SIX: LONN	$42.72B 33.71B CHF 4M%	37.2	Switzerland

chevron_leftBack